BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23373396)

  • 1. [Proton beam radiotherapy of uveal melanoma--preliminary results].
    Romanowska-Dixon B; Pogrzebielski A; Bogdali A; Markiewicz A; Swakoń J; Olko P; Jezabek M; Sas-Korczyńska B; Pluta E
    Klin Oczna; 2012; 114(3):173-9. PubMed ID: 23373396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoresection following proton beam irradiation of large uveal melanomas].
    Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
    Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
    Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
    Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool.
    Wright PK; Damato BE
    J R Coll Surg Edinb; 1999 Aug; 44(4):260-4. PubMed ID: 10453150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
    Hope-Stone L; Brown SL; Heimann H; Damato B
    Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Irish patients with intraocular melanoma referred to Liverpool, England.
    Kent D; Noonan CP; Damato BE
    Acta Ophthalmol Scand; 1998 Oct; 76(5):584-8. PubMed ID: 9826044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
    Marucci L; Ancukiewicz M; Lane AM; Collier JM; Gragoudas ES; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):842-6. PubMed ID: 20472356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France.
    Mosci C; Mosci S; Barla A; Squarcia S; Chauvel P; Iborra N
    Eur J Ophthalmol; 2009; 19(4):654-60. PubMed ID: 19551683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients.
    Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Dendale R; Delacroix S; Nauraye C; Estève M; Plancher C; Asselain B
    Ophthalmic Res; 2006; 38(5):255-60. PubMed ID: 16888407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
    Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye retention after proton beam radiotherapy for uveal melanoma.
    Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
    Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.